Kintor Pharmaceutical Limited
KNTPF
$0.3643
$0.034910.60%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.49% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.49% | -- | |||
| Cost of Revenue | -0.51% | 481.00% | |||
| Gross Profit | -0.57% | -32.61% | |||
| SG&A Expenses | -0.48% | 52.85% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 0.48% | -573.92% | |||
| Total Operating Expenses | -0.48% | 12.99% | |||
| Operating Income | 0.48% | -5.90% | |||
| Income Before Tax | 0.48% | -18.60% | |||
| Income Tax Expenses | -- | -100.00% | |||
| Earnings from Continuing Operations | 0.48% | -18.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.48% | -18.57% | |||
| EBIT | 0.48% | -5.90% | |||
| EBITDA | 0.48% | -5.23% | |||
| EPS Basic | 0.74% | -18.26% | |||
| Normalized Basic EPS | 0.00% | -8.33% | |||
| EPS Diluted | 0.74% | -18.26% | |||
| Normalized Diluted EPS | 0.00% | -8.33% | |||
| Average Basic Shares Outstanding | 0.00% | 0.14% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||